International Symposium on Biochip Techlogy and Molecular Classification of Disease

Biochip technology, which was established in 1990's, is a high-throughput approach for large-scale analysis of mole-cular profiles. Over the last decade, it has been widely accepted and used in functional genomics, disease genomics, pharmacogenomics and other life sciences. Pathological typing predominates disease classification, however, the inconsistency in treatment outcomes strongly demonstrates that the traditional method is not sufficient for clinical diagnosis. To date, biochip technology has been introduced in conducting disease classification around the globe. Exciting research results indicate that the technology could be a powerful tool in this area. In China, both the government and scientists have shown great concern to the progress of this novel research field. During the "Eleventh Five-year" period, "molecular classification of diseases" has been approved as a key project by "863" program comm-ittee and grants were offered to support scientific re-search and industrialization. To provide an opportunity to exchange experiences in molecular disease classification, and to establish future scientific collaborations, we, Shanghai Biochip Company/National Engineering Center for Biochip at Shanghai, will host the symposium in this May. We are pleased to invite your attendance.

Dr. Guoping Zhao, the director of National Engineering Certer for Biochip at Shanghai and an Academician of Chinese Academy of Science(CAS), will be the chairperson. The secretary-general will be Dr. Huasheng Xiao, the vice director of National Engineering Certer for Biochip at Shanghai.

Major Topics:
Ⅰ.Molecular classification of disease and  personalized medicine

Ⅱ.Microarray quality control and standardization

Ⅲ.Data analysis and data mining

Ⅳ.Clinical resource and Bio-bank

Ⅴ.New technology and application Conformed and invited speakers:
 
Keynote speakers: 
Professor Zhu Chen
 Shanghai Institute of Hematology
 
Dr.Stephen Friend
 Merck & Co.Inc.
 
Professor Shujun Chen
 Cancer Institute,Chinaese Academy of Medical Sciences
 
Professor Yixing Zhen
 Tumor Hospital affiliated to Zhongshan University
 

Additional speakers: 
Dr. Laura van't Veer
 The Netherlands Cancer Institute, Amsterdam, The Netherlands
 
Dr. Louis M. Staudt
 National Cancer Institute, Bethesda, MD
 
Dr. Jeffrey M. Trent
 Translational Genomics Research Institute, Phoenix, AZ
 
Dr. Todd R. Golub
 Broad Institute of Harvard and Massachusetts Institute of Technology, Boston, MA
 
Dr. Hyang-Sook Yoo
 Korea Research Institute of Bioscience and Biotechnology
 
Professor Qimin Zhan
 Cancer Institute, Chinese Academy of Medical Sciences
 
Professor Youyong Lv
 Peking University
 
Professor Zhimin Shao
 Cencer Hospital, Fudan University
 
Professor He lin
 Shanghai Jiao Tong University
 
Professor Jiarui Wu
 Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences
 
Professor Huang Wei
 Chinese National Human Genome Central at Shanghai
 
Professor Cheng Jing
 National Engineering Research Centre for Beijing Biochip Technology
 
Dr. Hongyue Dai
 Rosetta Inpharmatics Inc
 
Professor Guoping Zhao
 National Engineering Centre for Biochip at Shanghai
 
Professor Yixue Li
 Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences
 
Professor Xuegong Zhang
 Tisinghua University
 
Professor Yike Guo
 InforSense Ltd.
 
Professor Qinghua Zhou
 General Hospital of Tianjin Medical University
 
Professor Hengjun Gao
 Shanghai Outdo Biotech Co.,Ltd.
 
Professor Chen Chao
 Northwest University
 
Professor Zuhong Lu
 Southeast University 
 
Time:May 6-8th,2007
Location:151 Libing Rd.,Zhangjiang High-Tech Park,Shanghai,China
Sponsors:Affymetirx, Merck, Beckman
Organizer:Shanghai Biochip Co.,Ltd.
National Engineering Center for Biochip at Shanghai
 
Contact information
Phone:86-21-51320288-5221
Fax:86-21-51320266
Email:isbt@shbiochip.com
Contact person:Huasheng Xiao and Minghui Li
Working languages:English and Chinese